Company intelligence / Profile preview

AdyLife

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

AdyLife is a healthcare technology company focused on the field of longevity and proactive health management. The company provides a platform that integrates advanced diagnostics, including blood biomarkers and genetic testing, with personalized health optimization strategies. By leveraging data-driven insights, AdyLife aims to help individuals extend their healthspan and prevent chronic age-related conditions. Their services are designed to bridge the gap between traditional reactive medicine and proactive wellness through continuous monitoring and expert-led interventions.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Digital HealthDiagnostic
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on AdyLife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AdyLife.

Explore the full profile